Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-04-18

Clinical Trial Update: Tolerability and Efficacy of CD+A Compared to AQ+SP for the Treatment of P.Falciparum Malaria in Rwandan Children [NA]

View source ↗

Summary

A completed trial comparing tolerability and efficacy of CD+A (chlorproguanil-dapsone-artesunate) versus AQ+SP (amodiaquine-sulfadoxine-pyrimethamine) for P. fa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amodiaquine (Amodiaquine)
  • Artesunate (artesunate)
  • Chlorproguanil-dapsone (Chlorproguanil-dapsone)
  • Sulfadoxine-pyrimethamine (sulfadoxine-pyrimethamine)

Snippet

Sponsor: London School of Hygiene and Tropical Medicine | Conditions: Malaria | NA | Status: COMPLETED